Top Industry Leaders in the Arrhythmia Monitoring Devices Market
Latest Arrhythmia Monitoring Devices Companies Updates:
Philips' acquisition of BioTelemetry This strategic move strengthens Philips' cardiac monitoring and diagnostics offering with BioTelemetry's innovative software technology, ECG analysis, and reporting services.
AliveCor's KardiaMobile 6L lead approval This FDA-approved single-lead ECG device allows users to record and share six-lead quality electrocardiograms from their smartphones, potentially improving arrhythmia detection and diagnosis accessibility.
iRhythm Technologies' ZioXT wireless patch advancements The company received 510(k) clearance for its new and improved ZioXT monitor with enhanced signal quality and user comfort, along with updated AI capabilities for more accurate arrhythmia detection.
Spacelabs Healthcare's focus on implantable cardiac monitors This company continues to develop and refine its wireless implantable cardiac monitoring devices (ICMs) offering long-term monitoring and data insights for managing complex arrhythmias.
List of Arrhythmia Monitoring Devices Key companies in the market:
- Abbott Laboratories (US)
- BioTelemetry Inc. (US)
- Fukuda Denshi Co. Ltd (Japan)
- Applied Cardiac Systems Inc. (US)
- Medtronic plc (Ireland)
- Nihon Kohden Corporation (Japan)
- Alive Cor Inc. (US)
- Biotronik (Germany)
- GE Healthcare (US)
- Spacelabs Healthcare (US)